In August of 1997, the Food and Drug Administration (FDA) relaxed the rules governing television advertising of prescription pharmaceutical products allowing pharmaceuticals to mention both the disease and drug brand name. Shortly thereafter, expenditures on direct to consumer advertising (DTCA) for prescription pharmaceuticals rapidly expanded. This has prompted a great deal of debate in the medical profession and among health care insurers and managed care organizations regarding the effect of these marketing efforts. However, very little is known about the effects of DTCA for the efficient allocation of prescription drugs. There are three components to the effect of DTCA: a """"""""public good"""""""" effect whereby the information is disseminated about a disease, a """"""""matching"""""""" effect whereby the information in DTCA assists patients and physicians in identifying optimal therapeutic pathways, and a """"""""brand"""""""" effect whereby the DCTA encourages patient loyalty to the advertised brand based on the aesthetic or persuasive characteristics of the advertisements. The principal goal of this research will be to estimate bounds on these three effects, and thereby identify the helpful and/or harmful effects of DTCA on social welfare. We will bound the welfare effects by measuring how DTCA affects the likelihood that selected diseases are diagnosed, physician prescribing patterns given that the diseases are diagnosed, and the duration of care, conditional on a prescription being written. To do this, we will use data from two representative diseases: osteoarthritis and hyperlipidemia. The data will be taken from a large, geographically dispersed multi-practice electronic medical record research network, local data on television and radio advertisements, and other sources of local and national data. Knowledge gained about the impact of DTCA on the pathways of care will be have policy implications for private payors, future Medicare pharmaceutical benefits and the continued stance of the FDA on DTCA marketing rules.

Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Research Project (R01)
Project #
1R01HS011326-01A2
Application #
6614742
Study Section
Health Systems Research (HSR)
Program Officer
Hagan, Michael
Project Start
2003-07-07
Project End
2005-06-30
Budget Start
2003-07-07
Budget End
2004-06-30
Support Year
1
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Atkins, Danielle N; Bradford, W David (2015) Association between Increased Emergency Contraception Availability and Risky Sexual Practices. Health Serv Res 50:809-29
Bradford, W David; Lastrapes, William D (2014) A prescription for unemployment? Recessions and the demand for mental health drugs. Health Econ 23:1301-25
Bradford, W David; Kleit, Andrew N; Nietert, Paul J et al. (2006) How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior. Health Aff (Millwood) 25:1371-7
Bradford, W David; Kleit, Andrew N; Nietert, Paul J et al. (2006) Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals. Clin Ther 28:2105-18; discussion 2104